Recon

Geisinger, Medacta announce first shoulder replacement with lifetime guarantee

Program builds on the success of the health system’s ProvenCare® surgeries on hips, knees and spines

November 19, 2024 – WILKES-BARRE Pa. and CASTEL SAN PIETRO, Switzerland – Geisinger and the Medacta Group SA, a Swiss company specializing in innovative and sustainable solutions for joint replacement, sports medicine and spine surgeries, announced the first lifetime guarantee for a recent reverse shoulder replacement surgery. Geisinger and Medacta will stand behind the full cost of care throughout the patient’s lifetime.
 
Mark Pallis, D.O., Geisinger regional director of orthopaedic surgery, performed the first guaranteed reverse shoulder surgery at Geisinger South Wilkes-Barre.
 
“This is the first reverse shoulder arthroplasty with a lifetime guarantee in the world,” Dr. Pallis said. “We used state-of-the art intra-operative navigation to more accurately place the implants, using sensors to guide pin placement, reaming depth and screw length and position. The postoperative results were nearly identical to the preoperative plan based on 3D modeling from a CT scan of the shoulder.”
 
A reverse shoulder replacement is a specific type of total shoulder replacement commonly performed in patients who have arthritis as well as a torn or non-functioning rotator cuff. It is called a “reverse” because the ball portion of the shoulder is placed where the socket was, and the socket implant is placed where the head of the humerus was.
 
Medacta and Geisinger previously partnered on groundbreaking guarantees for qualified patients for hip and knee replacement surgeries and spinal fusion surgery as part of Geisinger’s ProvenCare® program, which covers inpatient and follow-up care for patients, including visits due to complications up to 90 days after the procedure.
 
“This new guarantee allows us to expand our ProvenCare® commitment to include patients who qualify for total shoulder replacement, offering those patients a sense of security when making the decision to have the procedure,” said Michael Suk, M.D., J.D., chair of the Department of Orthopaedic Surgery. “Standing behind our world-class joint replacement and spinal surgeries demonstrates Geisinger’s commitment to making better health easier for our patients and communities.” 

A global leader in orthopaedic medical devices, Medacta provides unique resources to train surgeons — including those at Geisinger — in surgical techniques and the use of their specially designed hip, knee, shoulder and spinal implants for minimally invasive surgeries. Medacta’s innovative technologies are designed to enable a healthy and active lifestyle for every patient, reducing postoperative pain and shortening rehabilitation time.

“The addition of the world’s first guarantee for reverse shoulder arthroplasty completes our robust offering of patient-focused guarantees for those undergoing hip, knee or spine procedures at Geisinger,” said Francesco Siccardi, CEO of Medacta International. “Through this initiative, we remain dedicated to improving outcomes for patients throughout their lifetimes.”

About Medacta
Medacta is a key global player specializing in the design, production, and distribution of innovative, personalized, and sustainable solutions for joint replacement, sports medicine, and spine surgery. Established in 1999 in Switzerland, Medacta is committed to improving the care and well-being of patients and maintains a strong focus on healthcare sustainability. Through close collaboration with expert surgeons globally, continuous investments in R&D, and the adoption of cutting-edge technologies, Medacta’s innovation prioritizes minimally invasive surgery and personalized solutions for every patient. Through the M.O.R.E. Institute, Medacta supports surgeons with a comprehensive and tailored program dedicated to the advancement of medical education. Medacta is headquartered in Castel San Pietro, Switzerland, and operates in over 60 countries. Follow us on Medacta TV, YouTube, LinkedIn and X.
 

About Geisinger
Geisinger is among the nation’s leading providers of value-based care, serving 1.2 million people in urban and rural communities across Pennsylvania. Founded in 1915 by philanthropist Abigail Geisinger, the nonprofit system generates $10 billion in annual revenues across 126 care sites — including 10 hospital campuses — and Geisinger Health Plan, with more than half a million members in commercial and government plans. Geisinger College of Health Sciences educates more than 5,000 medical professionals annually and conducts more than 1,400 clinical research studies. With 26,000 employees, including 1,700 employed physicians, Geisinger is among Pennsylvania’s largest employers with an estimated economic impact of $15 billion to the state’s economy. On March 31, 2024, Geisinger became the first member of Risant Health, a new nonprofit charitable organization created to expand and accelerate value-based care across the country. Learn more at geisinger.org or follow on FacebookInstagramLinkedIn and X.

Tim Allen

Medtech leader with 19+ years of experience in medical device product development, manufacturing, and project management.

Related Articles

Back to top button